Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Aldehyde doai
Patent
1995-06-06
1999-12-14
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Aldehyde doai
564387, 564389, 564390, 564392, 564655, A01N 3500
Patent
active
060018844
ABSTRACT:
The present invention features molecules which can modulate one or activities of an inorganic ion receptor. Preferably, the molecule can mimic or block the effect of extracellular Ca.sup.2+ on a calcium receptor. The preferred use of such molecules is to treat diseases or disorders by altering inorganic ion receptor activity, preferably calcium receptor activity.
REFERENCES:
patent: 2276618 (1942-03-01), Kulz et al.
patent: 2930731 (1960-03-01), Heinzelmann et al.
patent: 2949359 (1960-08-01), Blout et al.
patent: 3202711 (1965-08-01), Fruhstorfer et al.
patent: 3262977 (1966-07-01), Harsanyi et al.
patent: 3493662 (1970-02-01), Duerr et al.
patent: 3536712 (1970-10-01), Keck et al.
patent: 3689524 (1972-09-01), Jack et al.
patent: 3842067 (1974-10-01), Sarantakis
patent: 4000197 (1976-12-01), Barfknecht et al.
patent: 4014937 (1977-03-01), Richardson
patent: 4098890 (1978-07-01), Molloy
patent: 4242355 (1980-12-01), Nedelec et al.
patent: 4289787 (1981-09-01), Molloy et al.
patent: 4360511 (1982-11-01), Baldwin et al.
patent: 4391826 (1983-07-01), Mills et al.
patent: 4487965 (1984-12-01), Himmele et al.
patent: 4587253 (1986-05-01), Halczenko et al.
patent: 4591605 (1986-05-01), Ray
patent: 4608391 (1986-08-01), Ginos et al.
patent: 4609494 (1986-09-01), Baldwin
patent: 4647446 (1987-03-01), Sargent et al.
patent: 4661635 (1987-04-01), Carson
patent: 4675321 (1987-06-01), Baldwin
patent: 4677101 (1987-06-01), Claremon et al.
patent: 4728660 (1988-03-01), Haynes et al.
patent: 4769483 (1988-09-01), Lombardi et al.
patent: 4797411 (1989-01-01), Crugnola et al.
patent: 4808718 (1989-02-01), Hartman et al.
patent: 4839369 (1989-06-01), Youssefyeh et al.
patent: 4916145 (1990-04-01), Tilley et al.
patent: 4925664 (1990-05-01), Jackson et al.
patent: 4925873 (1990-05-01), Freidhoff
patent: 4967003 (1990-10-01), Rentzea et al.
patent: 4987071 (1991-01-01), Cech et al.
patent: 4988730 (1991-01-01), Korbonits et al.
patent: 4992378 (1991-02-01), Kelly et al.
patent: 5001251 (1991-03-01), MacManus et al.
patent: 5011834 (1991-04-01), Weber et al.
patent: 5021599 (1991-06-01), Beer et al.
patent: 5030576 (1991-07-01), Dull et al.
patent: 5034514 (1991-07-01), Nitecki et al.
patent: 5045466 (1991-09-01), Morrison
patent: 5053337 (1991-10-01), Weinshank et al.
patent: 5064657 (1991-11-01), Jackson et al.
patent: 5073648 (1991-12-01), Hagishita et al.
patent: 5075338 (1991-12-01), Knoll et al.
patent: 5082837 (1992-01-01), Palfreyman et al.
patent: 5298660 (1994-03-01), Yoneyoshi et al.
patent: 5334628 (1994-08-01), Maeda et al.
patent: 5403861 (1995-04-01), Goldin et al.
patent: 5504253 (1996-04-01), Van Wagenen et al.
patent: 5510519 (1996-04-01), Yoneyoshi et al.
patent: 5633404 (1997-05-01), Van Wagenen et al.
Takenaka, et al., J. Chem. Soc. Perkin Trans 2:EN; 95-99 (1978), "Induced Circular Dichroism of Chiral Amine-Benzoylbenzoic Acid Systems".
Lavanchy, Archives Des Sciences (Geneva), 11, 252-255 (1958).
Walker, et al., J. Med. Chem., 9(4), 624-30 (1966), "Synthesis of Varied Heterocyclic and Substituted Aryl Alkyl Secondary Amiones, relaed Schiff Bases, and Amides".
Giovambattista, et al., Ciencia e invest. (Buenos Aires) 14, 34-5 (1968), "Investigaciones Recientes".
West. et al., J. Am. Pharm. Assoc. 46. 58-61 (1957). "A pharmacological Study of a Series of Aralkylamines".
Majewski et al., "1,3-Dioxan-50 ones: synthesis, deprotonation, and reactions of their lithium enolates," Can. J. Chem. 73:1616-1625 (1995).
Majewski et al., "Synthesis of Butenolides via Enantioselective Deprotonation of Protected 4-Hydroxycyclohexanone," Tetrahedron Asymmetry 6:1837-1840 (1995).
Merck Index, 11th Edition, Monograph No. 2993, p. 475 (1989).
Polniaszek and Kaufman, "Steroselective Nucleophilic Additions to the Carbon-Nitrogen Double Bond. 2. Chiral Iminium Ions Derived from "Second Generation" Chiral Amines," J. Am. Chem. Soc. 111:4859-4863 (1989).
Abe et al., "Molecular Characterization of a Novel Metabotropic Glutamate Receptor mGluR5 Coupled to Inositol Phosphate/Ca.sup.2+ Signal Transduction," J. Biol. Chem., 267:13361-13368 (1992).
Barney et al., "A Convenient Synthesis of Hindered Amines and .alpha.-Trifluoromethylamines from Ketones," Tetrahedron Letters, 31:5547-5550 (1990).
Batra and Alenfall, "Effects of Diverse Categories of Drugs on Human Colon Tumour Cell Proliferation," Anticancer Research 11:1221-1224 (1991).
Becalski et al., "Catalytic asymmetric hydorgenation of imines. Use of rhodium(l)/phosphine comploexes and characterization of rhodium(l)/imine complexes," Chemical Abstracts, 116:558 at Abstract No. 14742U (1992).
Bertz et al., "Asymmetric Induction with Amidocuprates," J. Org. Chem. 51:4953-4959 (1986).
Bringmann et al., "Enantiomerically Pure-N-boc Protected .beta.-Keto-.gamma.-Amino Acid Esters from Simple Keto Precursors: A Novel, Stereocontrolled Approach to Statine Derivatives with Any Desired Configuration," Synlett pp. 253-255 (May 1990).
Bringmann et al., "The Enantioselective Synthesis of Optically Active, Benzene Nucleus-Substituted 1-Phenylethylamines from the Corresponding Acetophenones," Liebigs Ann. Chem. pp. 795-805 (1990).
Brown, "Extracellular Ca.sup.2+ Sensing, Regulation of Parathyroid Cell Function and Role of Ca.sup.2+ and Other Ions as Extracellular (First) Messengers," Physiological Reviews 71:371-411 (1991).
Brown et al, "Cloning and characterization of an extracellular Ca.sup.2+ sensing receptor from bovine parathryoid," Nature 366:575-580 (1993).
Brown et al., "A Comparison of the Effects of Divalent and Trivalent Cations on Parathyroid Hormone Release, 3',5'-Cyclic-Adenosine Monophosphate Accumulation, and the Levels of Inositol Phosphates in Bovine Parathyroid Cells," Endocrinology 127:1064-1071 (1990).
Brown et al., "High Extracellular Ca.sup.2+ and Mg.sup.2+ Stimulate Accumulation of Inositol Phosphates in Bovine Parathyroid Cells," FEBS Letters 218:113-118 (1987).
Brown et al., "Neomycin Mimics the Effects of High Extracellular Calcium Concentrations on Parathyroid Function in Dispersed Bovine Parathyroid Cells," Endocrinology, 128:3047-3054 (1991).
Brown et al., "Polyarginine, Polylysine, and Protamine Mimic the Effects of High Extracellular Calcium Concentrations on Dispersed Bovine Parathyroid Cells," J. Bone and Mineral Res., 6:1217-1225 (1991).
Capuano et al., "Characterization of the Human Calcium Receptor Gene," J. Bone and Mineral Research 9(1):S145 at 98 (1994).
Chemical Abstracts Formula Index, vol. 110 p. 537F (1989).
Chemical Abstracts Formula Index, vol. 110 p. 1793F (1989).
Chen et al., "Injection of Bovine Parathyroid Poly(A).sup.+ RNA into Xenopus Oocytes Confers Sensitivity to High Extracellular Calcium," J. Bone Min. Res. 9:293-300 (1994).
Chen and Brown, "The Diltiazem Analog TA-3090 Mimics the Actions of High Extracellular Ca.sup.2+ on Parathyroid Function in Dispersed Bovine Parathyroid Cells," J. Bone and Mineral Res., 5:581-587 (1990).
Clifton et al., "Arylethanolamines derived from salicylamide with alpha- and beta-adrenoceptor blocking activities. Preparation of labetalol, its enantiomers and related salicylamides," J. Med. Chem. 25:670-679 (1982).
Danks, "Reaction of Hydride Transfer Reducing Agents with (1-heterodiene) tricarbonyliron(0) Complexes and the Synthesis of Saturated Amines and Alcohols," Tetrahedron Lett. 35:4177-4178 (1994).
Davies and Ichihara, "Asymmetric Synthesis of R-.beta.-Amino Butanoic Acid and S-.beta.-Tyrosine: Homochiral Lithium Amide Equivalents for Michael Additions to .alpha.,.beta.-Unsaturated Esters," Tetrahedron: Asymmetry 2:183-186 (1991).
Dottavio-Martin and Ravel, "Radiolabeling of Proteins by Reductive Alkylation with [.sup.14 C]Formaldehyde and Sodium Cyanoborohydride," Analytical Biochem., 87:562-565 (1978).
Duelfer et al., "Synthesis of 14C-dilevalol," J. Labelled Compd. Radiopharm 25:855-863 (1988).
Fox et al., "A First Generation Calcimimetic Compound (NPS R-568) That Acts on the Parathyroid Cell Calcium Receptor: A Novel Therapeutic Approach for Hyperparathyroidism," J. Bone and Mineral Research 8(1):S181 at 260 (1993).
Fox et al., "NPS R-568 Inhibits Parathyroid Hormo
Balandrin Manuel F.
DelMar Eric G.
Moe Scott T.
Nemeth Edward F.
Van Wagenen Bradford C.
NPS Pharmaceuticals Inc.
Raymond Richard L.
LandOfFree
Calcium receptor-active molecules does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Calcium receptor-active molecules, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Calcium receptor-active molecules will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-863993